CHRISTIANSON MARK (Business Development Director) sold 3.2% of their position (8.98K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $5.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/23/2025ACC: 0001709738-25-000006
Officer· Business Development Director
Since Feb 2026
-8.98K
Net shares
Net seller
$5.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−14.00
Price / share
$0.65
Trade value
$9.10
% of position
0.0%
5/21/2025
280.47K→280.46K
Common Stock
Direct
Shares
−8.97K
Price / share
$0.62
Trade value
$5.59K
% of position
3.2%
5/22/2025
280.46K→271.49K
Total
Net shares
−8.98K
Net value
-$5.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2025 | S · Sale | −14.00 | $0.65 | $9.10 | 0.0% | 280.47K | 280.46K |
| Common Stock Direct | 5/22/2025 | S · Sale | −8.97K | $0.62 | $5.59K | 3.2% | 280.46K | 271.49K |
| Total | −8.98K | -$5.60K | ||||||
Derivative Transactions0
No derivative transactions reported